Artemether-lumefantrine for treating uncomplicated falciparum malaria [PDF]
Artemether-lumefantrine is being promoted by the World Health Organization for treating uncomplicated malaria. It is expensive. We sought evidence of its superiority over existing treatment regimens.To compare artemether-lumefantrine with other antimalarial drugs for treating uncomplicated falciparum malaria.We searched the Cochrane Infectious Diseases
A A, Omari, C, Preston, P, Garner
openaire +3 more sources
STATUS HEMATOLOGI PENDERITA MALARIA SEREBRAL
AbstrakMalaria masih merupakan masalah kesehatan masyarakat dunia. Berdasarkan klasifikasi klinis, malaria dibedakan atas malaria berat dan malaria tanpa komplikasi.
Nurhayati Nurhayati
doaj +1 more source
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. [PDF]
OBJECTIVE: In 2004, Sierra Leone adopted artesunate plus amodiaquine as first-line antimalarial treatment. We evaluated the efficacy of this combination in Kailahun, where a previous study had shown 70.2% efficacy of amodiaquine in monotherapy.
Balkan, S +8 more
core +2 more sources
Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria [PDF]
Systemic inflammation and sequestration of parasitized erythrocytes are central processes in the pathophysiology of severe Plasmodium falciparum childhood malaria. However, it is still not understood why some children are more at risks to develop malaria
Afolabi, Nathaniel K. +19 more
core +3 more sources
Introduction. Malaria is a leading cause of mortality among children below 5 years in Ghana. Its parasites are known to cause the degradation of hemoglobin, resulting in the production of reactive oxygen species and hence oxidant stress.
Kwabena Nsiah +5 more
doaj +1 more source
Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria [PDF]
The World Health Organization (WHO) recommends artemisinin-based combination therapy (ACT) for treating people with Plasmodium falciparum malaria. Five combinations are currently recommended, all administered over three days. Artemisinin-naphthoquine is a new combination developed in China, which is being marketed as a one-day treatment.
Isba, Rachel +3 more
openaire +3 more sources
Objective:Dihydroartemisinin-Piperaquine (DHP) combination is the first-line treatment for uncomplicated malaria in Indonesia and has been used since 2010.
Lambok Siahaan
doaj +1 more source
Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda. [PDF]
BACKGROUND: Most African countries have adopted artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria. The World Health Organization now recommends limiting anti-malarial treatment to those with a positive ...
Chang, Michelle +10 more
core +3 more sources
Predictive score of uncomplicated falciparum malaria patients turning to severe malaria [PDF]
In acute uncomplicated falciparum malaria, there is a continuum from mild to severe malaria. However, no mathematical system is available to predict uncomplicated falciparum malaria patients turning to severe malaria. This study aimed to devise a simple and reliable model of Malaria Severity Prognostic Score (MSPS).
Noppadon, Tangpukdee +8 more
openaire +2 more sources
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria [PDF]
The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria. Concerns about artemisinin resistance have led to global initiatives to develop new partner drugs to protect artemisinin derivatives in ACT.
Tilly Fox +3 more
openaire +2 more sources

